Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease

Summary

This study will examine the individual and combined effects of Coreg CR and lisinopril, on cardiovascular health as measured by Rasmussen Disease Score (RDS) in a blinded, placebo controlled comparison over a 9-month study period. Patients to be randomized will have pre-hypertensive blood pressures that do not require anti-hypertensive therapy and at least one additional cardiovascular risk factor.

Timeline

Start

2007-11

Primary completion

2010-09

Completion

2010-12

Drugs

Indications